JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armstrong, D. G.
Right arrow Articles by Welchon, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armstrong, D. G.
Right arrow Articles by Welchon, J. G.

Journal of the American Podiatric Medical Association, Vol 86, Issue 5 224-227, Copyright © 1996 by American Podiatric Medical Association

JOURNAL ARTICLE

Value of white blood cell count with differential in the acute diabetic foot infection

DG Armstrong, TA Perales, RT Murff, GW Edelson and JG Welchon
Department of Orthopaedics, University of Texas Health Sciences Center, San Antonio 78274-7776, USA.

The authors reviewed the admission leukocyte indices of 338 consecutive admissions (203 males, 135 females, mean age of 60.2 +/- 12.9 years) with a primary diagnosis of diabetic foot infection in a multicenter retrospective study. The mean white blood cell count on admission for all subjects studied was calculated at 11.9 +/- 5.4 x 103 cells/mm3. Of all white blood cell counts secured for patients admitted with a diabetic foot infection, 56% (189 out of 338) were within normal limits. The average automated polymorphonuclear leukocyte percentage was calculated at 71.4 +/- 11.1% (normal range 40% to 80%). Normal polymorphonuclear leukocyte values were present in 83.7% of subjects. The authors stress that the diagnosis of a diabetic pedal infection is made primarily on the basis of clinical signs and symptoms, and that a normal white cell count and white cell differential should not deter the physician from taking appropriate action to mitigate the propagation of a potentially limb-threatening pedal infection.


This article has been cited by other articles:


Home page
 Diabetes CareHome page
L. A. Lavery, D. G. Armstrong, E. J.G. Peters, and B. A. Lipsky
Probe-to-Bone Test for Diagnosing Diabetic Foot Osteomyelitis: Reliable or relic?
Diabetes Care, February 1, 2007; 30(2): 270 - 274.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
L. A. Lavery, D. G. Armstrong, R. P. Wunderlich, M. J. Mohler, C. S. Wendel, and B. A. Lipsky
Risk Factors for Foot Infections in Individuals With Diabetes.
Diabetes Care, June 1, 2006; 29(6): 1288 - 1293.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Podiatr. Med. Assoc.Home page
D. M. Kanuck, T. Zgonis, and G. P. Jolly
Necrotizing Fasciitis in a Patient with Type 2 Diabetes Mellitus
J Am Podiatr Med Assoc, January 1, 2006; 96(1): 67 - 72.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Podiatric Medical Association.